glp-1 in development What is the pipeline for future medications for obesity? Another milestone in the evolution
Description
Non-responders after gastric bypass surgery for morbid obesity: peptide hormones and glucose homeostasis

doi: 10.1056/NEJMoa2032183 20 FoxCKAuerbachPBarrientos-PrezMGiesIHalePMMarcusCet al

While diet can support your bodys natural GLP-1 response, it cant replicate the effects of these medications

Syneos Health Sector: Clinical R&D HQ: Morrisville, NC Year Founded: 1999 Key Leaders: Costa Panagos, CEO

Predictors for repeated hyperkalemia and potassium trajectories in high risk patientsa population-based cohort study
